Research Specifications

Sequence:: Tyr-hGH(177-191) — H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH
CAS:: 221231-10-3
Molecular Weight:: 1815.12 Da
Vial:: 5mg lyophilized
Purity:: ≥98% HPLC verified

AOD9604 5mg

Tyr-hGH 177-191 fragment

CAS: 221231-10-3

15 aa

Sequence length

C-terminal hGH

No IGF-1

Growth effect

Ng et al., 2000

β3-AR

Primary target

Lipolysis pathway

$62.99In Stock

Buy Now

≥98% Purity Verified Free Shipping $200+ HPLC Tested

Pairs Well With

CJC-1295 (no DAC)

Complementary GH pathway — natural pulse + lipolytic fragment

View compound →

Tesamorelin

Both target adiposity via different mechanisms

View compound →

Mixing & Storage

BAC Water

2mL

Final Concentration

2.5 mg/mL

Per Dose

250 μg = 0.1 mL (10 IU) · 500 μg = 0.2 mL (20 IU)

Typical research protocol: once daily fasted morning administration

Published References

1.
Ng FM, Sun J, Sharma L, et al.. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone Research (2000) PMID: 10970109
2.
Heffernan M, Summers RJ, Thorburn A, et al.. The effects of human GH and its lipolytic fragment (AOD9604). Endocrinology (2001) PMID: 11564725

Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.

Price Comparison

Supplier	Purity	Price	Shipping
our verified supplier	>98% HPLC	$62.99	Free over $200
Generic Research Suppliers	Varies (often <95%)	Similar–Higher	Varies
Pharmaceutical (Rx only)	Pharmaceutical grade	Not available for research	Rx required